JP2017518370A5 - - Google Patents

Download PDF

Info

Publication number
JP2017518370A5
JP2017518370A5 JP2017515014A JP2017515014A JP2017518370A5 JP 2017518370 A5 JP2017518370 A5 JP 2017518370A5 JP 2017515014 A JP2017515014 A JP 2017515014A JP 2017515014 A JP2017515014 A JP 2017515014A JP 2017518370 A5 JP2017518370 A5 JP 2017518370A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
composition according
eczema
filaggrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017515014A
Other languages
English (en)
Japanese (ja)
Other versions
JP6810028B2 (ja
JP2017518370A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032972 external-priority patent/WO2015184134A1/en
Publication of JP2017518370A publication Critical patent/JP2017518370A/ja
Publication of JP2017518370A5 publication Critical patent/JP2017518370A5/ja
Application granted granted Critical
Publication of JP6810028B2 publication Critical patent/JP6810028B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017515014A 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置 Active JP6810028B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462005652P 2014-05-30 2014-05-30
US201462005558P 2014-05-30 2014-05-30
US62/005,652 2014-05-30
US62/005,558 2014-05-30
PCT/US2015/032972 WO2015184134A1 (en) 2014-05-30 2015-05-28 Therapeutic tratment of skin disease with recombinant commensal skin microorganisms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020205127A Division JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Publications (3)

Publication Number Publication Date
JP2017518370A JP2017518370A (ja) 2017-07-06
JP2017518370A5 true JP2017518370A5 (2) 2018-07-12
JP6810028B2 JP6810028B2 (ja) 2021-01-06

Family

ID=54699800

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017515014A Active JP6810028B2 (ja) 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置
JP2020205127A Pending JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020205127A Pending JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Country Status (6)

Country Link
US (3) US10702558B2 (2)
EP (2) EP4144756A1 (2)
JP (2) JP6810028B2 (2)
ES (1) ES2929579T3 (2)
MA (1) MA40057A (2)
WO (1) WO2015184134A1 (2)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4144756A1 (en) 2014-05-30 2023-03-08 Azitra, Inc. Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
US9889165B2 (en) 2016-04-21 2018-02-13 Naked Biome, Inc. Compositions and methods for treatment of skin disorders
WO2018232300A1 (en) * 2017-06-16 2018-12-20 Azitra Inc Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes
MX2020002013A (es) * 2017-08-31 2020-07-13 Univ California Bacterioterapia molecular para control de la actividad enzimatica de la piel.
KR102834865B1 (ko) * 2017-09-05 2025-07-17 아지트라 인코포레이티드 재조합 미생물을 사용하여 염증성 피부 질환을 치료하기 위한 방법 및 조성물
AU2018379996A1 (en) 2017-12-05 2020-06-25 BioPlx, Inc. Methods and compositions to prevent microbial infection
JP7121969B2 (ja) * 2018-02-23 2022-08-19 株式会社北里コーポレーション 培養液保護用液状物
CN112236153B (zh) * 2018-04-05 2025-04-29 阿兹特拉公司 用重组微生物治疗皮肤疾病的方法和组合物
AU2019203692B2 (en) * 2018-08-30 2024-12-12 Kenvue Brands Llc Topical composition containing glycerin and yeast extract
CA3266235A1 (en) * 2018-09-26 2025-11-29 Krystal Biotech, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES
US20210355192A1 (en) * 2018-10-08 2021-11-18 Yale University Selective Binding and Aggregation of Human Keratin in the Skin Barrier Using Human Filaggrin Subdomains SD67 and SD150
AU2019378003A1 (en) * 2018-11-16 2021-05-20 Azitra Inc Auxotrophic strains of Staphylococcus bacterium
CZ308231B6 (cs) * 2019-02-11 2020-03-11 BiomCare s.r.o. Kombinované několikastupňové mikrobiální přípravky a způsob jejich aplikace
EP3946412A4 (en) * 2019-04-05 2023-01-04 Azitra, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF ATOPIC DERMATITIS WITH RECOMBINANT MICROORGANISMS
CA3143498A1 (en) * 2019-06-19 2020-12-24 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t-cells
KR20220133262A (ko) * 2020-01-29 2022-10-04 더 잭슨 래보라토리 박테리아 혼합물
WO2022087065A1 (en) * 2020-10-21 2022-04-28 The Jackson Laboratory Antimicrobial biosensors
JP2024506463A (ja) * 2021-01-05 2024-02-14 ラクトバイオ アー/エス 菌株、組成物および使用方法
CA3228922A1 (en) * 2021-10-11 2023-04-20 Ajinomoto Co., Inc. Bacterium modified to express heterologous tat protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0637384B2 (ja) * 1985-09-21 1994-05-18 株式会社資生堂 皮膚化粧料
US4659774A (en) 1985-11-01 1987-04-21 American Hoechst Corporation Support for solid-phase oligonucleotide synthesis
DE4221268C2 (de) 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221255C2 (de) 1992-06-26 1994-09-15 Lancaster Group Ag Phospholipide enthaltendes Kosmetikum
US20120295952A1 (en) * 2009-09-25 2012-11-22 Curna, Inc. Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
ES2645416T3 (es) 2009-11-23 2017-12-05 Research Development Foundation Polipéptidos de filagrina recombinantes para la importación a células
WO2011150127A2 (en) 2010-05-25 2011-12-01 The Board Of Trustees Of The University Of Illinois Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
MX2015001751A (es) * 2012-08-07 2015-11-13 Topgenix Inc Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.
KR101491240B1 (ko) 2013-03-15 2015-02-11 현대자동차주식회사 인비저블 슬라이딩 도어 링크 구조
EP4144756A1 (en) 2014-05-30 2023-03-08 Azitra, Inc. Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

Similar Documents

Publication Publication Date Title
JP2017518370A5 (2)
JP2024009974A5 (2)
CN108697743B (zh) 用于治疗由痤疮丙酸杆菌引起的感染尤其是痤疮的乳酸菌的组合物
JP2022501330A5 (2)
EP3849573B1 (en) Bacteriotherapy against proprionibacterium acnes for the treatment of acne
JP2016540825A5 (2)
CA3132858A1 (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
ES2682670T3 (es) Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
JPWO2019156137A5 (2)
WO2011013979A3 (ko) 봉독을 유효성분으로 하는 여드름 예방 및 치료용 조성물
MX2019003821A (es) Composiciones de aminoacidos y usos de las mismas.
JP2014518849A5 (2)
NZ627372A (en) Clostridium histolyticum enzymes and methods for the use thereof
JP2019500056A5 (2)
JP2016521746A5 (2)
RU2018124487A (ru) Лечение внутрипеченочного холестаза и родственных заболеваний печени
Dréno The microbiome, a new target for ecobiology in dermatology
JP2014505062A5 (2)
JP2020524689A5 (2)
NZ711281A (en) Short bio-active peptides for promoting wound healing
JP2017511133A5 (2)
MX2013010275A (es) Composicion para uso topico basada en aceite ozonizado.
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途